Spondyloarthrites, COVID-19 et biomédicaments anti-IL17
Par le Pr René-Marc Flipo (CHU - Lille) Article commenté :Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review ;Benlidayi IC et al. L’interleukine…